SimpleC Wellness Platform With Social Robot Interaction (Long-term)

March 18, 2024 updated by: SimpleC, LLC

Social Assistive Robot Interface for People With Alzheimers and Other Dementias to Aid in Care Management

This study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.

Study Overview

Detailed Description

This is a mixed-method study to assess the effectiveness of the SAR system. The study includes behavior/lifestyle intervention that are delivered via a robot and/or tablet. The study intervention is a Social Assistive Robot (SAR) System. The SAR system contains the SimpleC Platform, physical robot, virtual agent/robot.

The goal is to engage residents in a natural language conversation as psychosocial support (enhancing mood, mitigating the effects of loneliness, and enhancing social connection and communication) and provide value to the organization and its staff.

Research questions include:

  1. Are existing and new residents engaged and satisfied with the Technology Intervention Program?
  2. What are the benefits (health, behavioral, economic, and social) of the virtual agent and physical robot?
  3. Which users will adopt the SAR system?
  4. What are facilitators and barriers to SAR system adoption?
  5. Does Technology Acceptance Theory explain adoption over time?
  6. Do changing needs affect changing technology attitude?
  7. What are guidelines for implementation and design?

Sample: 270 individuals will participate: 90 residents, 90 family, and 90 staff across different study locations. Enrollment will be stopped upon reaching saturation.

  1. Participants in both conditions will have access to personal media, reminders, televisit, messaging, news, and wellness programs in their own room via the Companion.
  2. Participants in the SAR condition will have access to social and health reminders as well as social and wellness programs facilitated by a virtual robot agent in their own room via the Companion.
  3. Participants in the SAR condition will also have access to social and health reminders as well as social and wellness programs facilitated by a physical robot in the community area and a staff member (likely the activity director).

The goal is to offer SAR-facilitated group session at least once per week, for residents to attend at least one such session over the course of the study and two sessions/month.

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Georgia
      • Athens, Georgia, United States, 30602
        • University of Georgia
      • Atlanta, Georgia, United States, 30060
        • SimpleC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Resident Inclusion Criteria:

  • Aged 50+ years
  • Any gender
  • Fluent in English
  • New or current user of SimpleC
  • At risk for MCI; MCI; moderate / cognitive impairment (MMSE score of 13 or higher)

Family Member Inclusion Criteria:

  • Aged 18+ years
  • Any gender
  • Fluent in English
  • Family or friend of resident
  • New or current user of SimpleC
  • No diagnosis of dementia or related disorder

Staff Inclusion Criteria:

  • Aged 18+ years
  • Any gender
  • Fluent in English
  • Works for the Senior Housing Community
  • New or current user of SimpleC

Resident Exclusion Criteria:

  • Comorbidities or psychiatric history that would preclude study participation
  • Expecting to move during the study (i.e., move out of facility)
  • Both legally deaf and blind
  • Not able to press tablet buttons
  • Not able to verbally answer questionnaires
  • Pregnant

Family Caregiver Exclusion Criteria:

  • Comorbidities or psychiatric history that would preclude study participation
  • Expecting to move during the study (i.e., move out of facility)
  • Both legally deaf and blind
  • Not able to press tablet buttons
  • Pregnant

Staff Exclusion Criteria:

  • Expecting to move during the study (i.e., move out of facility)
  • Both legally deaf and blind
  • Pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SimpleC Wellness Platform with Social Robot Interaction
Participants in the Social Robot condition will have access to personal media, reminders, televisit, messaging, news, and wellness programs in their own room via the Companion. Participants will also will have access to social and health reminders as well as social and wellness programs facilitated by a virtual robot agent in their own room via the Companion, social and health reminders as well as social and wellness programs facilitated by a physical robot in the community area and a staff member (likely the activity director).
Traditional SimpleC Wellness
Robot interventions
Active Comparator: SimpleC Wellness Platform
Participants in the SimpleC Wellness Platform condition will have access to personal media, reminders, televisit, messaging, news, and wellness programs in their own room via the Companion.
Traditional SimpleC Wellness

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Robotic Social Attributes Scale (RoSAS). An 18-item scale with high scores indicating positive attitudes for dimensions of warmth and competency and a negative attitude for dimension of discomfort.
Time Frame: Midpoint (3 months), Final (6 months)
[Questionnaire] Perception and judgment of Social Assistive Robot social attributes on 3 dimensions: Warmth, competency, and discomfort
Midpoint (3 months), Final (6 months)
Change in Caregiver Guilt Scale. A 4-point scale with higher score indicating higher guilt.
Time Frame: Baseline, Midpoint (3 months), Final (6 months)
[Questionnaire] Family caregiver feelings of guilt.
Baseline, Midpoint (3 months), Final (6 months)
Change in Perceived Stress Scale. A 5-point scale with higher scores indicating higher stress.
Time Frame: Baseline, Midpoint (3 months), Final (6 months)
[Questionnaire] Family caregiver experience of stress in the past 4 months. Modification: Answer as it relates to caregiving.
Baseline, Midpoint (3 months), Final (6 months)
Change in Technology Acceptance and Experience Questionnaire. A scale with high scores indicating higher acceptance.
Time Frame: Midpoint (3 months), Final (6 months)
[Questionnaire] Assessment of users' perceived ease of use, usefulness, and satisfaction of using the technology.
Midpoint (3 months), Final (6 months)
Change in Quality of Life. A 13-item survey with high scores indicating higher quality of life.
Time Frame: Baseline, Midpoint (3 months), Final (6 months)
[Questionnaire] Assessment of different aspects of quality of life, including physical health, energy, family, money.
Baseline, Midpoint (3 months), Final (6 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technology acceptance and adoption Interview.
Time Frame: Midpoint (3 months)
[Interview] Assessment of users acceptance and adoption ease of use, usefulness, and satisfaction of using the technology.
Midpoint (3 months)
Technology acceptance and adoption Interview.
Time Frame: Final (6 months)
[Interview] Assessment of users acceptance and adoption ease of use, usefulness, and satisfaction of using the technology.
Final (6 months)
Usability and usefulness
Time Frame: 6 months
Identified factors that indicate the ease of use and usefulness for different tasks as derived from analysis of: [Interview, usage data]
6 months
Conversation quality
Time Frame: 6 months
[Interview] User perceptions on the usefulness and ease of use in conversing with the technology.
6 months
Value proposition/Economic Impact
Time Frame: 6 months
[Interview] Discussions with facility staff and key decision makers to understand the value of the technology in providing social interaction and reminders to their residents.
6 months
Requirements
Time Frame: 6 months
Identified requirements for design, training, and communication as derived from analysis of: [Interview, observations]
6 months
Affect
Time Frame: 6 months
[Interview] Feelings of enjoyment, satisfaction, when using the technology
6 months
Participation Pattern
Time Frame: 6 months
How often system is used, buttons clicked, voice activation [usage data, interview, observations]
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Anne Adams, PhD, SimpleC, LLC
  • Principal Investigator: Jenay M Beer, PhD, University of Georgia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 10, 2022

Primary Completion (Actual)

November 13, 2023

Study Completion (Actual)

November 13, 2023

Study Registration Dates

First Submitted

August 30, 2022

First Submitted That Met QC Criteria

October 25, 2022

First Posted (Actual)

October 31, 2022

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 18, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Behavioral Interventions

3
Subscribe